Literature DB >> 20580797

Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers.

Bing Wang1, Raghavendra S Navath, Anupa R Menjoge, Bindu Balakrishnan, Robert Bellair, Hui Dai, Roberto Romero, Sujatha Kannan, Rangaramanujam M Kannan.   

Abstract

Dendrimers have emerged as topical microbicides to treat vaginal infections. This study explores the in vitro, in vivo antimicrobial activity of PAMAM dendrimers, and the associated mechanism. Interestingly, topical cervical application of 500 microg of generation-4 neutral dendrimer (G(4)-PAMAM-OH) showed potential to treat the Escherichia coli induced ascending uterine infection in guinea pig model of chorioamnionitis. Amniotic fluid collected from different gestational sacs of infected guinea pigs posttreatment showed absence of E. coli growth in the cultures plated with it. The cytokine level [tumor necrosis factor (TNFalpha) and interleukin (IL-6 and IL-1beta)] in placenta of the G(4)-PAMAM-OH treated animals were comparable to those in healthy animals while these were notably high in infected animals. Since, antibacterial activity of amine-terminated PAMAM dendrimers is known, the activity of hydroxyl and carboxylic acid terminated PAMAM dendrimers was compared with it. Though the G(4)-PAMAM-NH(2) shows superior antibacterial activity, it was found to be cytotoxic to human cervical epithelial cell line above 10 microg/mL, while the G(4)-PAMAM-OH was non-cytotoxic up to 1mg/mL concentration. Cell integrity, outer (OM) and inner (IM) membrane permeabilization assays showed that G(4)-PAMAM-OH dendrimer efficiently changed the OM permeability, while G(4)-PAMAM-NH(2) and G(3.5)-PAMAM-COOH damaged both OM and IM causing the bacterial lysis. The possible antibacterial mechanism are G(4)-PAMAM-NH(2) acts as polycation binding to the polyanionic lipopolysaccharide in E. coli, the G(4)-PAMAM-OH forms hydrogen bonds with the hydrophilic O-antigens in E. coli membrane and the G(3.5)-PAMAM-COOH acts as a polyanion, chelating the divalent ions in outer cell membrane of E. coli. This is the first study which shows that G(4)-PAMAM-OH dendrimer acts as an antibacterial agent. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580797      PMCID: PMC2908334          DOI: 10.1016/j.ijpharm.2010.05.030

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  43 in total

Review 1.  Dendrimers in biomedical applications--reflections on the field.

Authors:  Sönke Svenson; Donald A Tomalia
Journal:  Adv Drug Deliv Rev       Date:  2005-11-21       Impact factor: 15.470

2.  Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates.

Authors:  Anupa R Menjoge; Raghavendra S Navath; Abbas Asad; Sujatha Kannan; Chong J Kim; Roberto Romero; Rangaramanujam M Kannan
Journal:  Biomaterials       Date:  2010-03-25       Impact factor: 12.479

3.  Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain.

Authors:  A Urakubo; L F Jarskog; J A Lieberman; J H Gilmore
Journal:  Schizophr Res       Date:  2001-01-15       Impact factor: 4.939

4.  Antimicrobial action of novel chitin derivative.

Authors:  Jae-Young Je; Se-Kwon Kim
Journal:  Biochim Biophys Acta       Date:  2005-10-17

5.  Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload.

Authors:  Parag Kolhe; Jayant Khandare; Omathanu Pillai; Sujatha Kannan; Mary Lieh-Lai; Rangaramanujam M Kannan
Journal:  Biomaterials       Date:  2005-07-27       Impact factor: 12.479

6.  Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study.

Authors:  Yiyun Cheng; Haiou Qu; Minglu Ma; Zhenhua Xu; Peng Xu; Yujie Fang; Tongwen Xu
Journal:  Eur J Med Chem       Date:  2007-01-20       Impact factor: 6.514

7.  Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and preterm parturition.

Authors:  J A Keelan; K W Marvin; T A Sato; M Coleman; L M McCowan; M D Mitchell
Journal:  Am J Obstet Gynecol       Date:  1999-12       Impact factor: 8.661

8.  Interaction of chitosans and their N-acylated derivatives with lipopolysaccharide of gram-negative bacteria.

Authors:  G A Naberezhnykh; V I Gorbach; G N Likhatskaya; V N Davidova; T F Solov'eva
Journal:  Biochemistry (Mosc)       Date:  2008-04       Impact factor: 2.487

9.  Transient lipopolysaccharide-induced cytokine responses in the maternal serum and amniotic fluid of the guinea pig.

Authors:  Michelle A Dickinson; Erica L Harnett; Carolina C Venditti; Graeme N Smith
Journal:  Am J Obstet Gynecol       Date:  2009-03-16       Impact factor: 8.661

10.  Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.

Authors:  Tathagata Dutta; Minakshi Garg; Narendra K Jain
Journal:  Vaccine       Date:  2008-05-12       Impact factor: 3.641

View more
  32 in total

1.  Membrane-active action mode of polybia-CP, a novel antimicrobial peptide isolated from the venom of Polybia paulista.

Authors:  Kairong Wang; Jiexi Yan; Ru Chen; Wen Dang; Bangzhi Zhang; Wei Zhang; Jingjing Song; Rui Wang
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

2.  Membrane perturbation action mode and structure-activity relationships of Protonectin, a novel antimicrobial peptide from the venom of the neotropical social wasp Agelaia pallipes pallipes.

Authors:  Kairong Wang; Wen Dang; Jiexi Yan; Ru Chen; Xin Liu; Wenjin Yan; Bangzhi Zhang; Junqiu Xie; Jindao Zhang; Rui Wang
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

3.  Two hits are better than one: membrane-active and DNA binding-related double-action mechanism of NK-18, a novel antimicrobial peptide derived from mammalian NK-lysin.

Authors:  Jiexi Yan; Kairong Wang; Wen Dang; Ru Chen; Junqiu Xie; Bangzhi Zhang; Jingjing Song; Rui Wang
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

4.  Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation.

Authors:  Raghavendra S Navath; Anupa R Menjoge; Hui Dai; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Mol Pharm       Date:  2011-06-20       Impact factor: 4.939

5.  Size of the nanovectors determines the transplacental passage in pregnancy: study in rats.

Authors:  Jerrie S Refuerzo; Biana Godin; Karen Bishop; Srimeenakshi Srinivasan; Shinil K Shah; Sarah Amra; Susan M Ramin; Mauro Ferrari
Journal:  Am J Obstet Gynecol       Date:  2011-04-08       Impact factor: 8.661

Review 6.  Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases.

Authors:  Meredith A Mintzer; Eric L Dane; George A O'Toole; Mark W Grinstaff
Journal:  Mol Pharm       Date:  2011-12-13       Impact factor: 4.939

7.  The introduction of L-phenylalanine into antimicrobial peptide protonectin enhances the selective antibacterial activity of its derivative phe-Prt against Gram-positive bacteria.

Authors:  Jinxiu Peng; Shuai Qiu; Fengjing Jia; Lishi Zhang; Yuhang He; Fangfang Zhang; Mengmeng Sun; Yabo Deng; Yifei Guo; Zhaoqing Xu; Xiaolei Liang; Wenjin Yan; Kairong Wang
Journal:  Amino Acids       Date:  2020-11-24       Impact factor: 3.520

8.  Nitric oxide-releasing amphiphilic poly(amidoamine) (PAMAM) dendrimers as antibacterial agents.

Authors:  Yuan Lu; Danielle L Slomberg; Anand Shah; Mark H Schoenfisch
Journal:  Biomacromolecules       Date:  2013-09-06       Impact factor: 6.988

Review 9.  Polymeric drugs: Advances in the development of pharmacologically active polymers.

Authors:  Jing Li; Fei Yu; Yi Chen; David Oupický
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

Review 10.  Nanoparticle-based drug delivery to the vagina: a review.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  J Control Release       Date:  2014-05-14       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.